Fatime S. Krasniqi
Basel, BS 4031, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 Trial.
Journal: Cancers
Published: April 18, 2026
SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma.
Journal: British journal of haematology
Published: February 04, 2026
Tumor-Infiltrating Lymphocyte Adoptive Cell Therapy With PD-1 Blockade in Pediatric Chemotherapy-Resistant Osteosarcoma.
Journal: Pediatric blood & cancer
Published: October 24, 2025
Perioperative Systemic Therapy in Rare, Chemosensitive Subtypes of Retroperitoneal Sarcoma: A Hospital-Based Propensity Score-Matched Analysis.
Journal: Cancers
Published: May 01, 2025
Case report: Histiocytic sarcoma as transdifferentiation of a marginal zone lymphoma-a case presentation based on post mortem examination and review of the literature.
Journal: Frontiers in oncology
Published: April 10, 2025
Case report: 'Atypical Richter transformation from CLL-type monoclonal B-cell lymphocytosis into Burkitt lymphoma in a treatment naïve patient'.
Journal: Frontiers in oncology
Published: September 18, 2023
Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin's lymphoma: results from the randomized international GHSG HD18 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 18, 2023
SAKK57/16 Nab-paclitaxel and Gemcitabine in Soft Tissue Sarcoma (NAPAGE): a phase I/II trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 04, 2023
Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis.
Journal: Histopathology
Published: July 20, 2023
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma.
Journal: Blood advances
Published: November 02, 2021
Last Updated: 09/26/2026